Reuters logo
4 个月前
BRIEF-Egalet announces U.S. FDA acceptance of file for prior approval supplement for Oxaydo
2017年4月18日 / 上午10点39分 / 4 个月前

BRIEF-Egalet announces U.S. FDA acceptance of file for prior approval supplement for Oxaydo

April 18 (Reuters) - Egalet Corp

* Egalet announces U.S. Food and Drug Administration acceptance of file for prior approval supplement for Oxaydo(oxycodone HCL, USP) tablets C-II 10 mg and 15 mg dosage strengths

* Egalet Corp - FDA goal date is June 17, 2017

* Egalet Corp - there is no evidence that Oxaydo has reduced abuse liability compared to immediate-release oxycodone Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below